Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UHT
2076
Universal Health Realty Income Trust
UHT
$592M
| $16.9M | ﹤0.01% |
283,400
-3
| -0% | -$174 |
|
2077
Clearfield
CLFD
$436M
| $16.8M | ﹤0.01% |
199,401
+212
| +0.1% | +$13.3K |
|
|
NBIS
2078
Nebius Group N.V.
NBIS
$54B
| $16.8M | ﹤0.01% |
277,891
-11,509
| -4% | -$848K |
|
2079
PDF Solutions
PDFS
$2.01B
| $16.7M | ﹤0.01% |
526,875
+20,415
| +4% | +$568K |
|
2080
Syndax Pharmaceuticals
SNDX
$1.7B
| $16.7M | ﹤0.01% |
764,627
+31,407
| +4% | +$580K |
|
|
SGMO
2081
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $16.7M | ﹤0.01% |
2,229,183
+33,840
| +2% | +$294K |
|
|
LBAI
2082
DELISTED
Lakeland Bancorp Inc
LBAI
| $16.7M | ﹤0.01% |
877,173
+6,769
| +0.8% | +$124K |
|
2083
Amphastar Pharmaceuticals
AMPH
$892M
| $16.6M | ﹤0.01% |
714,873
+10,958
| +2% | +$224K |
|
2084
ACV Auctions
ACVA
$1.36B
| $16.6M | ﹤0.01% |
882,727
+488,859
| +124% | +$9.6M |
|
2085
Consensus Cloud Solutions
CCSI
$690M
| $16.6M | ﹤0.01% |
+287,182
| New | +$17.5M |
|
|
MGP
2086
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $16.5M | ﹤0.01% |
404,911
-2,854
| -0.7% | -$112K |
|
2087
Castle Biosciences
CSTL
$928M
| $16.5M | ﹤0.01% |
385,741
+20,373
| +6% | +$1.06M |
|
|
ZGNX
2088
DELISTED
Zogenix, Inc.
ZGNX
| $16.5M | ﹤0.01% |
1,014,355
-69,420
| -6% | -$1.02M |
|
2089
Rocket Pharmaceuticals
RCKT
$372M
| $16.5M | ﹤0.01% |
754,627
+2,766
| +0.4% | +$75.5K |
|
2090
Origin Bancorp
OBK
$1.69B
| $16.4M | ﹤0.01% |
382,057
+441
| +0.1% | +$19.4K |
|
2091
Myers Industries
MYE
$1.38B
| $16.4M | ﹤0.01% |
818,976
+13,096
| +2% | +$265K |
|
|
TBI
2092
Trueblue
TBI
$229M
| $16.4M | ﹤0.01% |
591,467
-544
| -0.1% | -$15.4K |
|
2093
MacroGenics
MGNX
$243M
| $16.4M | ﹤0.01% |
1,018,761
-23,244
| -2% | -$437K |
|
2094
Interface
TILE
$2.03B
| $16.3M | ﹤0.01% |
1,021,142
+2,199
| +0.2% | +$34.2K |
|
|
EMBK
2095
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $16.3M | ﹤0.01% |
+93,698
| New | +$17.1M |
|
|
SLGC
2096
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $16.2M | ﹤0.01% |
1,396,017
+1,346,462
| +2,717% | +$16.1M |
|
2097
Columbia Financial
CLBK
$1.11B
| $16.2M | ﹤0.01% |
778,308
-39,523
| -5% | -$767K |
|
2098
Joby Aviation
JOBY
$7.84B
| $16.2M | ﹤0.01% |
2,222,291
+70,747
| +3% | +$588K |
|
2099
Vanda Pharmaceuticals
VNDA
$315M
| $16.1M | ﹤0.01% |
1,027,258
+16,554
| +2% | +$288K |
|
|
ENDP
2100
DELISTED
Endo International plc
ENDP
| $16.1M | ﹤0.01% |
4,280,507
+425,177
| +11% | +$2.06M |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.